Iduronate-2-sulfatase (IDS)
Assets acting on this target.
- Class
- Gene therapy delivering the IDS gene to the central nervous system
By indication
Related mechanisms
Iduronate-2-sulfatase (IDS) drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Tividenofusp alfaAvlayah | Denali Therapeutics | fusion_protein | Approved | Approved in Mucopolysaccharidosis Type II |
| Clemidsogene lanparvovec | Nippon Shinyaku, REGENXBIO Inc. | gene therapy | Phase 3 | Phase 3 in Mucopolysaccharidosis Type II |